Cutaquig (Human Normal Immunoglobulin)

Cutaquig is a subcutaneous immunoglobulin therapy used to treat primary immunodeficiency diseases. This product helps support the immune system in individuals with weakened immune responses.

Cutaquig is primarily used for the treatment of primary immunodeficiency diseases. These conditions occur when the body's immune system is not functioning properly, leaving individuals more susceptible to infections. By providing additional antibodies, Cutaquig helps to strengthen the immune system and reduce the risk of infections. It is administered subcutaneously, which means it is injected under the skin.

Common effects of Cutaquig may include redness, swelling, or itching at the injection site. Some individuals might experience mild to moderate discomfort during or after administration. These effects are generally temporary and should subside over time. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Cutaquig should be handled with care and stored according to the manufacturer's instructions to maintain its effectiveness. It is important to follow proper administration techniques to minimize the risk of infection or other complications. Individuals with a history of severe allergic reactions to immunoglobulin products should use Cutaquig with caution.

Cutaquig may interact with certain medications or substances. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect the immune system should be used with caution while undergoing treatment with Cutaquig.